Delivery Order SPE2DB20D3505-SPE2DB25FT9L8

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,989.58 firm fixed-price contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The total ceiling value of this delivery order is $20,627.77. The contract is a Firm Fixed Price (FFP) instrument with a period of performance through November 30, 2023. Amerisourcebergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $3,519.37 and a period of performance ending on March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp. The contract, valued at $5,170.92, is for the delivery of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The contract has a period of performance through March 4, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor under this award, which is not designated as a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The contract has a total ceiling value of $12,898.98 and is a Firm Fixed Price contract running through May 30, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for the treatment of type 2 diabetes. The contract has a ceiling value of $3,759.96 and a completion date of January 7, 2025. It is a firm fixed-price contract and was not set aside for any specific business size or...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $57,900.75 and a period of performance through April 30, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3mL, a medication used to treat diabetes. The delivery order has a ceiling value of $24,262.44 and a completion date of March 18, 2025. The contract is a firm fixed-price type without any set-aside requirements, indicating open competition. AmerisourceBergen holds...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The $16,147.84 firm fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, as well as with the Department of Justice...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.74 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT9L8
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for diabetes management. The delivery order has a ceiling value of $1,879.98 and a completion date of February 5, 2025. This contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen, a for-profit organization, is the prime contractor for this award, which is part of the company's broader portfolio of federal contracts with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively. These contracts enable the government to efficiently procure a wide range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.

Generated 5/6/25, 11:46 AM